Towards a more precise classification of esophageal motility disorders in patients with systemic sclerosis

Elisa Marabotto,Vincenzo Savarino,Edoardo Savarino

DOI: https://doi.org/10.1111/nmo.14416

2022-05-21

Abstract:The presence of esophageal dysfunction is a good prognostic indicator in SSc, primarily due to its impact on pulmonary disease. Currently, the detection of esophageal motility alterations is possible thanks to the use of high‐resolution (−impedance) esophageal manometry and functional luminal imaging probe. In this mini‐review, we summarize current evidence regarding esophageal dysmotility in patients with SSc. Systemic sclerosis (SSc) is a chronic and generalized disease affecting the connective tissue of the skin and many internal organs, in particular the gastrointestinal tract. The esophagus is involved in up to 80% of the cases and represents a major cause of serious morbidities that deeply impact on the quality of life and survival of patients. Indeed, the presence of esophageal dysfunction is a good prognostic indicator in SSc, primarily due to its impact on pulmonary disease. Thus, the detection of esophageal motility alterations plays a critical role to prevent the development of both esophageal and pulmonary complications and to improve the survival of these patients. Currently, this diagnostic work‐up has been limited to the use of esophageal manometry, which is considered the gold standard for the evaluation of motor physiology and pathophysiology of this organ in different clinical situations. However, in recent years, new equipments such as high‐resolution (−impedance) manometry and functional luminal imaging probe have been developed and used in many esophageal clinical settings, including SSc. In this mini‐review, we summarize current evidence regarding esophageal dysmotility, in the light of new data on secondary peristalsis published in this issue of the journal.

gastroenterology & hepatology,neurosciences,clinical neurology